What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability.
10.3760/cma.j.issn.1007-3418.2014.06.001
- Author:
Ding JIA
1
;
Hong WANG
;
Jian WU
Author Information
1. Department of Infectious Diseases, Zhengzhou University People's Hospital, Zhengzhou 450003, China.
- Publication Type:Journal Article
- MeSH:
Antigens, Neoplasm;
immunology;
Cancer Vaccines;
immunology;
Carcinoma, Hepatocellular;
immunology;
therapy;
Humans;
Immunotherapy;
Liver Neoplasms;
immunology;
therapy
- From:
Chinese Journal of Hepatology
2014;22(5):393-396
- CountryChina
- Language:Chinese
